Table 4 Total change scores for outcomes from baseline to follow up points for completers and intention to treat analysis
| Â | Per protocol analysis | Intention to treat analysis | ||
|---|---|---|---|---|
| Â | LT Group (n = 13) Median (IQR) | MT Group (n = 10) Median (IQR) | LT Group (n = 16) Median (IQR) | MT Group (n = 14) Median (IQR) |
Total change score RMDQ | Â | Â | Â | Â |
   baseline to post treatment | 5.5 (4.5) | 3 (5.5) | 4.5 (7.3) | 3 (8) |
   baseline to 3 months | 6 (7.5) | 5 (15.8) | 6 (7.8) | 5 (15) |
   baseline to 6 months | 7 (7) | 5.5 (11.3) | 4 (12.3) | 3 (12.3) |
Total change score MPQ-PRI | Â | Â | Â | Â |
   baseline to post treatment | 18 (7.8) | 16 (27) | 17.5 (12.8) | 15.5 (25.8) |
   baseline to 3 months | 15.5 (33.8) | 15 (33.8) | 14.4 (14.3) | 15.4 (31.3) |
   baseline to 6 months | 12 (10.5) | 19.5 (25.8) | 11.5 (17.3) | 16.5 (30.8) |
Total change score SF36 PCS | Â | Â | Â | Â |
   baseline to post treatment | -8.9 (13.9) | -.9 (18.4) | -7.5 (14.6) | -0.5 (13.7) |
   baseline to 3 months | -15.8 (18.4) | -2.1 (16) | -12.3 (14.2) | -1.6 (17.4) |
   baseline to 6 months | -10.5 (13.3) | -3.80 (18.8) | -10.2 (10.2) | -4.6 (17.5) |
Total change score SF36 MCS | Â | Â | Â | Â |
   baseline to post treatment | -4.9 (8.1) | -1 (16.9) | -2.1 (8.5) | -1 (11.9) |
   baseline to 3 months | -5.7 (18.2) | +1.6 (13.9) | -0.3 (16.7) | +1.6 (13.3) |
   baseline to 6 months | -7.2 (16.2) | -4.4 (21.6) | -2.3 (15.9) | -2.9 (10.1) |